Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations-10 Children and Review of the Literature.

Autor: Deyà-Martínez A; Study Group for Immune Dysfunction Diseases in Children (GEMDIP), Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Clinical Immunology and Primary Immunodeficiencies Unit, Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Spain.; Clinical Immunology Program Hospital, Sant Joan de Déu-Hospital Clínic Barcelona, Barcelona, Spain., Rivière JG; Infection in Immunocompromised Pediatric Patients Research Group, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Catalonia, Spain.; Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Catalonia, Spain.; Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain., Roxo-Junior P; Division of Immunology and Allergy, Dept of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Ramakers J; Department of Pediatrics, Hospital Universitari Son Espases, Palma, Spain.; Multidisciplinary Group for Research in Peadiatrics, Hospital Universitari Son Espases, Balearic Islands Health Research Institute (IdISBa), Palma, Spain., Bloomfield M; Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.; Department of Pediatrics, 1st Faculty of Medicine, Charles University in Prague, Thomayer University Hospital, Prague, Czech Republic., Guisado Hernandez P; Laboratorio de Alteraciones Congénitas de La Inmunidad, Instituto de Biomedicina de Sevilla (IBiS), Laboratorio 205, Seville, Spain., Blanco Lobo P; Laboratorio de Alteraciones Congénitas de La Inmunidad, Instituto de Biomedicina de Sevilla (IBiS), Laboratorio 205, Seville, Spain., Abu Jamra SR; Division of Immunology and Allergy, Dept of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil., Esteve-Sole A; Study Group for Immune Dysfunction Diseases in Children (GEMDIP), Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Clinical Immunology and Primary Immunodeficiencies Unit, Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Spain.; Clinical Immunology Program Hospital, Sant Joan de Déu-Hospital Clínic Barcelona, Barcelona, Spain., Kanderova V; Inborn Errors of Immunity Group, Laboratory 205, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain., García-García A; Study Group for Immune Dysfunction Diseases in Children (GEMDIP), Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Clinical Immunology and Primary Immunodeficiencies Unit, Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Spain.; Clinical Immunology Program Hospital, Sant Joan de Déu-Hospital Clínic Barcelona, Barcelona, Spain., Lopez-Corbeto M; Pediatric Rheumatology Unit, Rheumatology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Catalonia, Spain., Martinez Pomar N; Immunology Department, Hospital Universitari Son Espases, Palma, Spain.; Human Immunopathology Research Laboratory, Institut d'Investigació Sanitària de Les Illes Balears (IdISBa), Palma, Spain., Martín-Nalda A; Infection in Immunocompromised Pediatric Patients Research Group, Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Catalonia, Spain.; Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Catalonia, Spain.; Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain., Alsina L; Study Group for Immune Dysfunction Diseases in Children (GEMDIP), Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Clinical Immunology and Primary Immunodeficiencies Unit, Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Spain.; Clinical Immunology Program Hospital, Sant Joan de Déu-Hospital Clínic Barcelona, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain., Neth O; Laboratorio de Alteraciones Congénitas de La Inmunidad, Instituto de Biomedicina de Sevilla (IBiS), Laboratorio 205, Seville, Spain. oneth-ibis@us.es.; Pediatric Infectious Diseases, Rheumatology and Immunology Unit, Hospital Universitario Virgen del Rocio, Sevilla, Spain. oneth-ibis@us.es., Olbrich P; Laboratorio de Alteraciones Congénitas de La Inmunidad, Instituto de Biomedicina de Sevilla (IBiS), Laboratorio 205, Seville, Spain. polbrich@us.es.; Pediatric Infectious Diseases, Rheumatology and Immunology Unit, Hospital Universitario Virgen del Rocio, Sevilla, Spain. polbrich@us.es.; Departamento de Farmacología, Pediatría y Radiología. Facultad de Medicina, Universidad de Sevilla, Seville, Spain. polbrich@us.es.

Publikováno v: Journal of clinical immunology [J Clin Immunol] 2022 Jul; Vol. 42 (5), pp. 1071-1082. Date of Electronic Publication: 2022 Apr 29.